journal article·2024-05Open access

Composition‐Reinforced Polydopamine Nanoenzyme for Improved Impairment of Prostatitis‐Damaged Sexual Behavior and Enhanced Anti‐Prostate Cancer

Keyi Wang, Weipu Mao, Xinran Song, Wei Feng, Guangchun Wang, Tao Zhang, Tianyuan Xu, Ming Chen, Yu Chen, Bo Peng

Advanced Functional Materials· Volume 34· Issue 19

Abstract

Abstract Inflammation is pivotal in the pathogenesis and progression of the most challenging diseases and even cancer. Nanomedicine‐based strategy can be referred as a distinct solution to this complicated clinical obstacle by proposing an elaborated combination of effective therapeutic performances on inflammation and cancer. Herein, 2,2,6,6‐tetramethylpiperidine‐1‐oxyl doped polydopamine nanoparticles, termed as TPDA NPs, with the significantly improved reactive oxygen/nitrogen species (RO/NSs) scavenging performance and enhanced photothermal efficiency are designed and synthesized by constructing donor‐acceptor pairs, for prostate diseases treatment including anti‐inflammation and anti‐tumor. Benefiting from mimicking multi‐natural enzymes, including superoxide dismutase, catalase, peroxidase, and glutathione peroxidase, TPDA NPs can inhibit the NF‐κB signaling pathways by downregulating the CD36 expression for the treatment of oxidative stress‐induced prostatitis. Especially, TPDA NPs can improve the prostatitis‐associated impairment of sexual behavior. By virtue of the enhanced photothermal‐conversion efficiency, TPDA NPs ablate prostate cancer and simultaneously decrease inflammatory reaction. Therefore, this work provides a “three birds with one shot” paradigm to utilize rationally designed TPDA NPs for efficient management of prostate diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai 200072 P. R. China

Department of Urology Affiliated Zhongda Hospital of Southeast University Nanjing 210009 P. R. China

Materdicine Lab School of Life Sciences Shanghai University Shanghai 200444 P. R. China

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine Vision and Brain Health) Wenzhou Institute of Shanghai University Wenzhou Zhejiang 325088 P. R. China

Department of Urology Putuo People's Hospital School of Medicine Tongji University Shanghai 200060 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province

References (68)

Show source-provided references
1. 10.1016/j.juro.2015.05.10010.1016/j.juro.2015.05.100 ↗
2. 10.1111/bju.1295110.1111/bju.12951 ↗
3. 10.1016/S0302-2838(03)00370-110.1016/S0302-2838(03)00370-1 ↗
4. 10.1001/jama.282.3.23610.1001/jama.282.3.236 ↗
5. 10.1016/j.eururo.2015.08.06110.1016/j.eururo.2015.08.061 ↗
6. 10.1016/S0090-4295(98)00390-210.1016/S0090-4295(98)00390-2 ↗
7. 10.1016/S0022-5347(05)67497-610.1016/S0022-5347(05)67497-6 ↗
8. 10.1016/S0090-4295(99)00613-510.1016/S0090-4295(99)00613-5 ↗
9. 10.1002/pros.2150210.1002/pros.21502 ↗
10. 10.1016/j.semcancer.2021.11.00110.1016/j.semcancer.2021.11.001 ↗
11. 10.1038/nrurol.2017.16710.1038/nrurol.2017.167 ↗
12. 10.3322/caac.2166010.3322/caac.21660 ↗
13. 10.1001/jama.2017.724810.1001/jama.2017.7248 ↗
14. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
15. 10.1007/s12274-018-2092-y10.1007/s12274-018-2092-y ↗
16. 10.1021/acsnano.8b0402210.1021/acsnano.8b04022 ↗
17. Dai X. · Angew. Chem., Int. Ed. · 2023
18. 10.1016/j.actbio.2023.02.02610.1016/j.actbio.2023.02.026 ↗
19. 10.1158/1055-9965.EPI-19-038710.1158/1055-9965.EPI-19-0387 ↗
20. 10.1002/ijc.3156510.1002/ijc.31565 ↗
21. 10.1038/nrurol.2016.8910.1038/nrurol.2016.89 ↗
22. 10.3390/antiox812061610.3390/antiox8120616 ↗
23. Song J. · Andrology · 2020
24. 10.3390/antiox902013410.3390/antiox9020134 ↗
25. Wang K. · Chem. Soc. Rev. · 2023
26. 10.1093/humrep/der13210.1093/humrep/der132 ↗
27. 10.1155/2016/914092510.1155/2016/9140925 ↗
28. 10.1093/humupd/dmn00410.1093/humupd/dmn004 ↗
29. 10.1002/anie.20150243010.1002/anie.201502430 ↗
30. Zhang Y. · 2016 · 1387
31. 10.1021/jacs.5b1207010.1021/jacs.5b12070 ↗
32. 10.1002/anie.20160086810.1002/anie.201600868 ↗
33. Wang K. · Adv. Funct. Mater. · 2021
34. Huang Y. · Angew. Chem. Int. Ed.
35. Huo M. · ACS Nano · 2019 · 13 · 2643
36. 10.1002/EXP.2021008910.1002/EXP.20210089 ↗
37. 10.1021/acs.bioconjchem.1c0008110.1021/acs.bioconjchem.1c00081 ↗
38. 10.1021/la104981s10.1021/la104981s ↗
39. 10.1186/s12917-016-0792-710.1186/s12917-016-0792-7 ↗
40. 10.1021/acs.jafc.5b0473910.1021/acs.jafc.5b04739 ↗
41. 10.1186/s12929-016-0268-x10.1186/s12929-016-0268-x ↗
42. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
43. 10.1021/jacs.5b1207010.1021/jacs.5b12070 ↗
44. 10.1002/adfm.20210922110.1002/adfm.202109221 ↗
45. 10.1002/anie.20210103310.1002/anie.202101033 ↗
46. 10.1021/tx990159t10.1021/tx990159t ↗
47. 10.1016/j.jhep.2018.04.00610.1016/j.jhep.2018.04.006 ↗
48. 10.1038/ni.183610.1038/ni.1836 ↗
49. Sp N. · Nutrients · 2018 · 10
50. 10.7150/thno.3402410.7150/thno.34024 ↗
51. 10.1007/s10753-020-01384-w10.1007/s10753-020-01384-w ↗
52. 10.1007/s00011-017-1094-710.1007/s00011-017-1094-7 ↗
53. 10.1111/and.1411310.1111/and.14113 ↗
54. 10.3389/fimmu.2020.57421210.3389/fimmu.2020.574212 ↗
55. 10.1002/pros.2391310.1002/pros.23913 ↗
56. 10.1007/s10753-020-01326-610.1007/s10753-020-01326-6 ↗
57. 10.1186/s12950-019-0224-010.1186/s12950-019-0224-0 ↗
58. 10.1016/j.eururo.2015.08.06110.1016/j.eururo.2015.08.061 ↗
59. Wang G. C. · J Inflamm (Lond) · 2020 · 17
60. 10.21037/apm-20-98510.21037/apm-20-985 ↗
61. 10.1038/nature0720510.1038/nature07205 ↗
62. 10.1002/marc.20190026310.1002/marc.201900263 ↗
63. 10.1007/s11426-020-9797-310.1007/s11426-020-9797-3 ↗
64. 10.1126/sciadv.abb469610.1126/sciadv.abb4696 ↗
65. 10.1002/adma.20120468310.1002/adma.201204683 ↗
66. 10.1038/s41467-020-14963-010.1038/s41467-020-14963-0 ↗
67. 10.1038/s41419-020-2381-810.1038/s41419-020-2381-8 ↗
68. 10.1016/S1470-2045(05)70168-610.1016/S1470-2045(05)70168-6 ↗